Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong Diabetes Registry.

Yang X, So WY, Ma RC, Kong AP, Lee HM, Yu LW, Chow CC, Ozaki R, Ko GT, Chan JC.

Diabetes Care. 2011 Feb;34(2):375-80. doi: 10.2337/dc10-1509. Epub 2010 Oct 27.

PMID:
20980414
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry.

Yang X, So WY, Ma RC, Kong AP, Lee HM, Xu G, Ozaki R, Chan JC.

Acta Diabetol. 2012 Dec;49 Suppl 1:S185-93. doi: 10.1007/s00592-012-0409-y. Epub 2012 Jun 22.

PMID:
22722949
[PubMed - indexed for MEDLINE]
3.

Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Yang X, So WY, Ma RC, Ko GT, Kong AP, Zhao H, Luk AO, Lam CW, Ho CS, Tong PC, Chan JC.

Diabetes Care. 2009 Oct;32(10):1826-32. doi: 10.2337/dc09-0725. Epub 2009 Jul 10.

PMID:
19592629
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Use of thiazolidinedione and cancer risk in Type 2 diabetes: the Hong Kong diabetes registry.

Yang X, So WY, Ma RC, Yu LW, Kong AP, Lee HM, Xu G, Ozaki R, Ko GT, Chan JC.

Diabetes Res Clin Pract. 2012 Jul;97(1):e13-7. doi: 10.1016/j.diabres.2012.03.006. Epub 2012 Apr 11.

PMID:
22502769
[PubMed - indexed for MEDLINE]
5.

Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes.

Lawrence JM, Reid J, Taylor GJ, Stirling C, Reckless JP.

Diabetes Care. 2004 Jan;27(1):41-6.

PMID:
14693964
[PubMed - indexed for MEDLINE]
6.

One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH; QUARTET Study Group.

Diabetes Care. 2004 Jan;27(1):141-7.

PMID:
14693980
[PubMed - indexed for MEDLINE]
7.

Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry.

Yang X, So WY, Ma RC, Kong AP, Xu G, Chan JC.

Diabetes Metab Res Rev. 2012 Jul;28(5):379-87. doi: 10.1002/dmrr.2287. Epub 2012 Feb 8. Review.

PMID:
22318884
[PubMed - indexed for MEDLINE]
8.

Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus.

Yang X, So W, Ko GT, Ma RC, Kong AP, Chow CC, Tong PC, Chan JC.

CMAJ. 2008 Aug 26;179(5):427-37. doi: 10.1503/cmaj.071474.

PMID:
18725615
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

Diabetes Care. 1998 May;21(5):701-5.

PMID:
9589227
[PubMed - indexed for MEDLINE]
10.

Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-The Hong Kong Diabetes Registry.

So WY, Yang X, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V, Tong PC, Chan JC.

Diabetes Metab Res Rev. 2008 Mar-Apr;24(3):238-46.

PMID:
17992700
[PubMed - indexed for MEDLINE]
11.

Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.

Wang JS, Lin SD, Lee WJ, Su SL, Lee IT, Tu ST, Tseng YH, Lin SY, Sheu WH.

Clin Ther. 2011 Dec;33(12):1932-42. doi: 10.1016/j.clinthera.2011.10.014. Epub 2011 Nov 10.

PMID:
22078152
[PubMed - indexed for MEDLINE]
12.
13.

The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.

Comaschi M, Corsi A, Di Pietro C, Bellatreccia A, Mariz S; COM06 Study Investigators.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):373-9. Epub 2007 Oct 24.

PMID:
17919894
[PubMed - indexed for MEDLINE]
14.

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes.

Libby G, Donnelly LA, Donnan PT, Alessi DR, Morris AD, Evans JM.

Diabetes Care. 2009 Sep;32(9):1620-5. doi: 10.2337/dc08-2175. Epub 2009 Jun 29.

PMID:
19564453
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.

Wulffelé MG, Kooy A, de Zeeuw D, Stehouwer CD, Gansevoort RT.

J Intern Med. 2004 Jul;256(1):1-14. Review.

PMID:
15189360
[PubMed - indexed for MEDLINE]
16.

Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes.

Yang X, Zhao H, Sui Y, Ma RC, So WY, Ko GT, Kong AP, Ozaki R, Yeung CY, Xu G, Tong PC, Chan JC.

Diabetes. 2009 Jul;58(7):1518-25. doi: 10.2337/db09-0105. Epub 2009 Apr 28.

PMID:
19401427
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Bowker SL, Majumdar SR, Veugelers P, Johnson JA.

Diabetes Care. 2006 Feb;29(2):254-8.

PMID:
16443869
[PubMed - indexed for MEDLINE]
18.

Alcohol consumption and diabetes risk in the Diabetes Prevention Program.

Crandall JP, Polsky S, Howard AA, Perreault L, Bray GA, Barrett-Connor E, Brown-Friday J, Whittington T, Foo S, Ma Y, Edelstein SL; Diabetes Prevention Program Research Group.

Am J Clin Nutr. 2009 Sep;90(3):595-601. doi: 10.3945/ajcn.2008.27382. Epub 2009 Jul 29.

PMID:
19640960
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients.

Monami M, Colombi C, Balzi D, Dicembrini I, Giannini S, Melani C, Vitale V, Romano D, Barchielli A, Marchionni N, Rotella CM, Mannucci E.

Diabetes Care. 2011 Jan;34(1):129-31. doi: 10.2337/dc10-1287. Epub 2010 Oct 27.

PMID:
20980415
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes.

Yang X, Wang Y, Luk AO, So WY, Ma RC, Kong AP, Xu G, Chan JC.

Endocr Relat Cancer. 2013 Mar 22;20(2):161-71. doi: 10.1530/ERC-12-0290. Print 2013 Apr.

PMID:
23250907
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk